Skip to main content
Premium Trial:

Request an Annual Quote

Faysal Sohail, J. Craig Venter, Tony White

Premium

CMEA Ventures of San Francisco has named Faysal Sohail as a venture partner. Prior to joining CMEA, Sohail was CEO of Cadabra Design Automation and managed its acquisition by Numerical Technologies, where he served as senior vice president of worldwide field operations.

 

J. Craig Venter has stepped down as president of Celera Genomics. Venter led the company through its much-publicized sequencing of the human genome, but is leaving the post so that a replacement can lead Celera further “downstream” into pharmaceutical development. Venter, who helped found The Institute for Genomic Research (TIGR), plans to spend more time working as chairman of the organization. Applera CEO Tony White will serve as interim president of Celera until a replacement for Venter can be found.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.